Search - tctmd.com

Displaying 701 - 720 of 928

Sort: Relevancy | Date

Presentation TCT 2016

An Alcohol Septal Ablation Case I Regret

Presenter: Srihari S. Naidu, Paul Sorajja

October 30, 2016

Presentation TCT 2016

My Best Alcohol Septal Ablation Case

Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel

October 30, 2016

Presentation TCT 2016

Good and Not So Good Cases to Consider for Alcohol Septal Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, John S. Douglas Jr

October 30, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD!

Presenter: Bernard J. Gersh, Harry Rakowski, George S. Hanzel

October 30, 2016

Presentation TCT 2016

When Is Pacing Needed in HCM Outside Invasive Management Settings

Presenter: Bernard J. Gersh, Harry Rakowski

October 30, 2016

Presentation TCT 2016

Medical Management of Non-Obstructive HCM: When and Which Medications?

Presenter: Bernard J. Gersh, Harry Rakowski, John S. Douglas Jr

October 30, 2016

Presentation TCT 2016

Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening

Presenter: Howard C. Herrmann, Sherif F. Nagueh, Robert Roberts

October 30, 2016

Presentation TCT 2016

Cardiac Catheterization Is Essential for Hemodynamic Assessment

Presenter: Howard C. Herrmann, Sherif F. Nagueh

October 30, 2016

Presentation TCT 2016

Cardiac MR for Diagnosis and Guiding Management of HCM

Presenter: Howard C. Herrmann, Sherif F. Nagueh, Andrew E. Arai

October 30, 2016

Presentation TCT 2016

Echocardiography Essentials for Comprehensive Evaluation of HCM

Presenter: Howard C. Herrmann, Sherif F. Nagueh

October 30, 2016

News Daily News

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Michael O'Riordan

October 17, 2016

News Industry News

Heart Metabolics Announces Initiation Of Phase 2b Study Of Perhexiline For Hypertrophic Cardiomyopathy

August 31, 2016

News Conference News ESC 2016

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

Shelley Wood

August 29, 2016

News Conference News ESC 2016

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Michael O'Riordan

August 28, 2016

News Conference News ESC 2016

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Shelley Wood

August 28, 2016

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

L.A. McKeown

August 24, 2016

News Daily News

基因检测不一定是 HCM 诊断的最后一根稻草

Yael L. Maxwell

August 23, 2016

News Daily News

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Yael L. Maxwell

August 23, 2016

News Daily News

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Yael L. Maxwell

August 23, 2016

Advertisement

An Alcohol Septal Ablation Case I Regret

My Best Alcohol Septal Ablation Case

Good and Not So Good Cases to Consider for Alcohol Septal Ablation

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD!

When Is Pacing Needed in HCM Outside Invasive Management Settings

Medical Management of Non-Obstructive HCM: When and Which Medications?

Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening

Cardiac Catheterization Is Essential for Hemodynamic Assessment

Cardiac MR for Diagnosis and Guiding Management of HCM

Echocardiography Essentials for Comprehensive Evaluation of HCM

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Heart Metabolics Announces Initiation Of Phase 2b Study Of Perhexiline For Hypertrophic Cardiomyopathy

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

基因检测不一定是 HCM 诊断的最后一根稻草

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content